BOTHELL, Wash.—Helix BioMedix announced several new happenings. First, DermaVenture LLC won the Electronic Retailing Association’s ERA Award for the Best U.S. Hispanic Long Form Show (infomercial) of 2008; the spot features the P.A.C. Perfect™ product line, developed by DermaVenture and Helix BioMedix.
Also, Helix BioMedix’s licensee, Evonik, a division of Goldschmidt GmbH, presented data at the International Federation of Societies of Cosmetic Chemists (IFSCC) Congress in Barcelona, Spain. The 60 subject study showed an increased expression of ECM-synthesizing enzymes including hyaluronic acid synthase, as well as expression and production of ECM proteins like collagen and fibronectin with topical application of H14. Launching its first Helix BioMedix peptide under the trade name Tego®Pep 4-17, Evonik is working on additional Helix BioMedix peptides through its own research and in collaboration with leading universities.
Finally, Helix launched the Striking™ Skin Care with SmartPeptides™ product line, the first proprietary branded products released by Helix. They use the SmartPeptide™ Heptapeptide-7 to nourish keratinocytes for enhanced skin renewal, and will be initially marketed via catalog and online. R. Stephen Beatty, president/CEO, Helix BioMedix, said, “Tests have shown that SmartPeptides boost collagen production and support the skin’s extracellular matrix, thereby reducing the appearance of fine lines and wrinkles while increasing the overall firmness of the skin.”